105 related articles for article (PubMed ID: 25543508)
1. [Expression and Significance of PTPL1 in Hematological Malignancies].
Wang WM; Wang J; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1744-7. PubMed ID: 25543508
[TBL] [Abstract][Full Text] [Related]
2. PTPN13/PTPL1: an important regulator of tumor aggressiveness.
Freiss G; Chalbos D
Anticancer Agents Med Chem; 2011 Jan; 11(1):78-88. PubMed ID: 21235435
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
[TBL] [Abstract][Full Text] [Related]
4. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
[TBL] [Abstract][Full Text] [Related]
5. Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.
Abaan OD; Hendriks W; Uren A; Toretsky JA; Erkizan HV
Exp Cell Res; 2013 Jan; 319(1):1-11. PubMed ID: 23018179
[TBL] [Abstract][Full Text] [Related]
6. 5-Azacitidine induces demethylation of PTPL1 and inhibits growth in non-Hodgkin lymphoma.
Wang W; Wang J; Li M; Ying J; Jing H
Int J Mol Med; 2015 Sep; 36(3):698-704. PubMed ID: 26133246
[TBL] [Abstract][Full Text] [Related]
7. PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells.
Castilla C; Chinchón D; Medina R; Torrubia FJ; Japón MA; Sáez C
Cell Death Dis; 2013 Apr; 4(4):e576. PubMed ID: 23559010
[TBL] [Abstract][Full Text] [Related]
8. PTPL1: a large phosphatase with a split personality.
Abaan OD; Toretsky JA
Cancer Metastasis Rev; 2008 Jun; 27(2):205-14. PubMed ID: 18265946
[TBL] [Abstract][Full Text] [Related]
9. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.
Dromard M; Bompard G; Glondu-Lassis M; Puech C; Chalbos D; Freiss G
Cancer Res; 2007 Jul; 67(14):6806-13. PubMed ID: 17638892
[TBL] [Abstract][Full Text] [Related]
10. [Methylation Status of PTPL1 Gene in Non-Hodgkin's Lymphoma Cells].
Wang WM; Wang J; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1596-600. PubMed ID: 26708878
[TBL] [Abstract][Full Text] [Related]
11. Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.
Révillion F; Puech C; Rabenoelina F; Chalbos D; Peyrat JP; Freiss G
Int J Cancer; 2009 Feb; 124(3):638-43. PubMed ID: 19004008
[TBL] [Abstract][Full Text] [Related]
12. The Phosphatase PTPL1 Is Required for PTEN-Mediated Regulation of Apical Membrane Size.
Bruurs LJM; van der Net MC; Zwakenberg S; Rosendahl Huber AKM; Post A; Zwartkruis FJ; Bos JL
Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29581186
[TBL] [Abstract][Full Text] [Related]
13. [PTPL1, a proapoptotic protein tyrosine phosphatase in breast cancers].
Freiss G; Bompard G; Vignon F
Bull Cancer; 2004 Apr; 91(4):325-32. PubMed ID: 15242314
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.
Wang J; Li S; Zhang X; Zhu N; Yiminniyaze R; Dong L; Li C; Gulinuer W; Xia J; Li J; Zhou D; Liu X; Zhang Y; Zhang Y; Li S
Thorac Cancer; 2022 Nov; 13(21):3042-3051. PubMed ID: 36193770
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.
Kimber WA; Deak M; Prescott AR; Alessi DR
Biochem J; 2003 Dec; 376(Pt 2):525-35. PubMed ID: 14516276
[TBL] [Abstract][Full Text] [Related]
16. Membrane targeting of protein tyrosine phosphatase PTPL1 through its FERM domain via binding to phosphatidylinositol 4,5-biphosphate.
Bompard G; Martin M; Roy C; Vignon F; Freiss G
J Cell Sci; 2003 Jun; 116(Pt 12):2519-30. PubMed ID: 12766187
[TBL] [Abstract][Full Text] [Related]
17. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.
Abaan OD; Levenson A; Khan O; Furth PA; Uren A; Toretsky JA
Oncogene; 2005 Apr; 24(16):2715-22. PubMed ID: 15782144
[TBL] [Abstract][Full Text] [Related]
18. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
Wang LQ; Liang R; Chim CS
Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
[TBL] [Abstract][Full Text] [Related]
19. [Advances of research on demethylation therapy for hematologic malignancies].
Chen CH; Yang JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1394-8. PubMed ID: 19840491
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase L1 inhibits high-grade serous ovarian carcinoma progression by targeting IκBα.
Wang Y; Li M; Huang T; Li J
Onco Targets Ther; 2018; 11():7603-7612. PubMed ID: 30464509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
